- Parties: The plaintiffs were Leo Pharma Inc. and Leo Pharma A/S. The defendant was Glenmark Pharmaceuticals Canada Inc.

- Subject Matter: This Federal Court matter involves a patent infringement action commenced under section 6(1) of the Patented Medicines (Notice of Compliance) Regulations, wherein the Plaintiffs allege that the Defendant's proposed pharmaceutical product will infringe Canadian Patent No. CA2800181 covering topical spray compositions containing a vitamin D derivative and a corticosteroid, while the Defendant denies infringement and asserts the patent is invalid on grounds of anticipation and obviousness. The case is ongoing.

- Date: The hearing was set on March 05, 2026.

- Venue: This was a federal case before the Federal Court.

- Amount: No financial award was specified.